Company intelligence / Profile preview

Platanus

San Francisco, California, United Statesplatanus.hr ↗
Ownership
Private
Development stage
Other
01

Overview

Platanus is a global evergreen investment fund specializing in venture capital for innovative biotechnology and healthcare startups. The firm invests across therapeutic modalities and indications with transformative potential. Representative investments include Ray Therapeutics (optogenetics for blinding eye disease), Perfuse Therapeutics, Semma Therapeutics (acquired by Vertex Pharmaceuticals), Akouos (acquired by Eli Lilly), Korro Bio, Inipharm, Callio Therapeutics (multi-payload ADCs for cancer), and Nuvig (protein therapeutics for autoimmune disease).

Therapeutic areas
OncologyOphthalmologyImmunology
Modalities
Antibody-drug conjugateProtein therapeuticsMonoclonal antibodySmall moleculeGene therapy
Industry
Investors
02

Partnerships

Novo Holdings A/SNorwest Venture PartnersFrazier Life SciencesJeito CapitalBristol Myers SquibbDigitalis VenturesMission BioCapitalOmega FundsClavystBioPureos BioventuresSEEDS CapitalEDBI

Beyond the preview

Go deeper on Platanus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platanus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call